Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Kanumuambidi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancers|November 27, 2025
Histology-Specific Survival in Penile Squamous Cell Carcinoma: A SEER-Based Study Highlighting Human Papillomavirus Status and Prognostic SubtypesYudai Ishiyama, Arjun Venkatesh, Reynier David Rodriguez Rosales, et al.
Urologic Oncology|April 16, 2026
An integrated restricted mean survival time-based evaluation of efficacy, toxicity, and cost in first-line immunotherapy regimens for metastatic renal cell carcinomaYudai Ishiyama, Arjun Venkatesh, Joseph McGrath, et al.
The Prostate|April 17, 2026
Protein Kinase D1 Translocates PARP1 to the Membrane and Is Associated With Increased Sensitivity to Cell Viability Inhibition by PARP1 Inhibitor OlaparibSanjeev Shukla, Joseph McGrath, Robert Willis, et al.
Investigational New Drugs|February 20, 2026
A novel aurora kinase molecular glue-based degrader sp-2-067 inhibits prostate cancer cell growth and alters immune profileSanjeev Shukla, Sarah Pogash, Arjun Venkatesh, et al.
Urologic Oncology|August 1, 2025
An RMST-based analysis of systemic therapy in muscle-invasive bladder cancerArjun Venkatesh, Yudai Ishiyama, Reynier D Rodriguez Rosales, et al.
The Prostate|October 5, 2025
Genetics-Driven, Intensity-Modulated Adaptive Management of Patients With Metastatic Prostate CancerReynier D Rodriguez Rosales, Arjun Venkatesh, Jean-Pierre Kanumuambidi, et al.
Cancers|March 14, 2026
Role of Spatial Heterogeneity in Muscle-Invasive Bladder Cancer on Overall Survival and Immunotherapy ResponseArjun Venkatesh, Reynier D Rodriguez Rosales, Jean-Pierre Kanumuambidi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancers|November 27, 2025
Histology-Specific Survival in Penile Squamous Cell Carcinoma: A SEER-Based Study Highlighting Human Papillomavirus Status and Prognostic SubtypesYudai Ishiyama, Arjun Venkatesh, Reynier David Rodriguez Rosales, et al.
Urologic Oncology|April 16, 2026
An integrated restricted mean survival time-based evaluation of efficacy, toxicity, and cost in first-line immunotherapy regimens for metastatic renal cell carcinomaYudai Ishiyama, Arjun Venkatesh, Joseph McGrath, et al.
The Prostate|April 17, 2026
Protein Kinase D1 Translocates PARP1 to the Membrane and Is Associated With Increased Sensitivity to Cell Viability Inhibition by PARP1 Inhibitor OlaparibSanjeev Shukla, Joseph McGrath, Robert Willis, et al.
Investigational New Drugs|February 20, 2026
A novel aurora kinase molecular glue-based degrader sp-2-067 inhibits prostate cancer cell growth and alters immune profileSanjeev Shukla, Sarah Pogash, Arjun Venkatesh, et al.
Urologic Oncology|August 1, 2025
An RMST-based analysis of systemic therapy in muscle-invasive bladder cancerArjun Venkatesh, Yudai Ishiyama, Reynier D Rodriguez Rosales, et al.
The Prostate|October 5, 2025
Genetics-Driven, Intensity-Modulated Adaptive Management of Patients With Metastatic Prostate CancerReynier D Rodriguez Rosales, Arjun Venkatesh, Jean-Pierre Kanumuambidi, et al.
Cancers|March 14, 2026
Role of Spatial Heterogeneity in Muscle-Invasive Bladder Cancer on Overall Survival and Immunotherapy ResponseArjun Venkatesh, Reynier D Rodriguez Rosales, Jean-Pierre Kanumuambidi, et al.
Pageof 1